ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
0,00%
Bitcoin
63.027,77
-1,35%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Quest Diagnostics Inc (DGX)

  7. Quest Diagnostics Inc (DGX) News

DGX

Quest Diagnostics (DGX)

Quest Diagnostics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:DGX
DatumZeitQuelleÜberschriftSymbolFirma
01/05/202412h57PR Newswire (US)Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAINYSE:DGXQuest Diagnostics Inc
23/04/202412h45PR Newswire (US)Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024NYSE:DGXQuest Diagnostics Inc
22/04/202413h53PR Newswire (US)Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's DiseaseNYSE:DGXQuest Diagnostics Inc
02/04/202413h57PR Newswire (US)Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental DelayNYSE:DGXQuest Diagnostics Inc
26/03/202412h09PR Newswire (US)Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's DiseaseNYSE:DGXQuest Diagnostics Inc
19/03/202420h06PR Newswire (US)Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024NYSE:DGXQuest Diagnostics Inc
01/03/202422h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202422h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202422h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202422h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202422h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202422h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202422h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202422h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
01/03/202422h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
29/02/202419h50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DGXQuest Diagnostics Inc
29/02/202419h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DGXQuest Diagnostics Inc
28/02/202417h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DGXQuest Diagnostics Inc
27/02/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
27/02/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
27/02/202422h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
27/02/202422h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
27/02/202422h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
27/02/202422h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
23/02/202422h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
23/02/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
23/02/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
23/02/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
23/02/202422h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
23/02/202422h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
 Showing the most relevant articles for your search:NYSE:DGX

Kürzlich von Ihnen besucht

FX
EURGBP
Euro vs Sterling
TG
ALV
Allianz
COIN
BTCUSD
Bitcoin
NASDAQ
AMZN
Amazon.com
AMEX
SPY
SPDR S&P 500
DBI
SDXP
SDAX
TG
432
Arbor Metals
TG
BAS
BASF
COIN
SOLUSD
Solana
CCOM
US500
US 500
NASDAQ
NVDA
NVIDIA
TG
LHA
Deutsche Lufthansa
NASDAQ
TSLA
Tesla
TG
MBG
MercedesBenz
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten